What Are Peptides and Why Are Women Interested?

Peptides are short chains of amino acids — smaller than full proteins, larger than individual amino acids — that act as biological signaling molecules. The body makes thousands of peptides naturally; synthetic versions of specific peptides can be administered to amplify or replicate signals that may decline with age, stress, illness, or hormonal shifts.

Women are increasingly drawn to peptide therapy for reasons that map closely to how hormonal changes affect them: declining growth hormone output after 30, reduced collagen synthesis after menopause, connective tissue vulnerability postpartum, sexual health changes, and the desire to preserve muscle and skin quality as they age. The key is matching the right peptide to the right goal with appropriate evidence behind it.

PT-141 (Bremelanotide): The Only FDA-Approved Peptide for Women's Sexual Health

PT-141 is unique among peptides discussed for women's health: it has FDA approval. Approved in 2019 under the brand name Vyleesi, bremelanotide is indicated for hypoactive sexual desire disorder (HSDD) in premenopausal women — defined as persistently low sexual desire that causes meaningful distress.

Unlike hormone-based treatments, PT-141 works centrally — it activates melanocortin receptors in the brain, specifically the hypothalamus, to enhance sexual motivation and arousal. It is administered as a subcutaneous injection 45 minutes before anticipated sexual activity. Clinical trials showed statistically significant improvements in desire and reductions in distress compared to placebo, with the most common side effects being transient nausea and flushing.

PT-141 is also used off-label for postmenopausal women with HSDD and shows similar benefits in this population. It does not work like a hormone and does not carry the same risks as estrogen — making it a useful option for women who cannot or prefer not to use hormonal therapy.

BPC-157: Gut Healing and Connective Tissue

Body Protection Compound-157 (BPC-157) is a synthetic peptide derived from a protein found in human gastric juice. It has robust animal data and growing anecdotal clinical reports supporting its role in accelerating healing of gut mucosa, tendons, ligaments, and muscle tissue. Human clinical trials are limited but ongoing.

For women specifically, BPC-157 is gaining attention in several contexts: gut-related symptoms (IBS, leaky gut, gastritis), postpartum connective tissue recovery (ligament laxity and pelvic floor tissue is common after childbirth), and sports injury recovery. It is typically administered via subcutaneous injection or orally (for gut-specific effects). The oral route is practical and well-tolerated; evidence suggests it retains activity through the GI tract, which is unusual for peptides.

Safety data from animal studies is excellent, and no serious adverse events have been reported in human use — but the absence of large human RCTs means this remains in the "promising, physician-supervised" category rather than "proven."

GHK-Cu: Skin, Hair, and Wound Healing

GHK-Cu (copper peptide GHK) is one of the most studied peptides for skin and hair applications. It naturally declines with age and is detectable in plasma, saliva, and urine. Research shows it stimulates collagen and elastin synthesis, promotes wound healing, has anti-inflammatory properties, and activates hair follicle stem cells.

For women, the two primary applications are topical skincare (GHK-Cu serums and creams are well-evidenced for improving skin laxity, fine lines, and wound healing) and systemic use for hair loss support (GHK-Cu injected or applied topically to the scalp may enhance minoxidil's effects and improve follicle health directly). Systemic GHK-Cu is also being studied for its broader anti-aging effects, including gene expression modulation — early research is compelling though not yet at the clinical guideline level.

CJC-1295 / Ipamorelin: Growth Hormone Support for Women 40+

CJC-1295 is a growth hormone releasing hormone (GHRH) analogue; Ipamorelin is a selective growth hormone secretagogue. Used together, they stimulate the pituitary gland to release growth hormone in a pulsatile, physiological pattern — replicating the natural GH pulses that decline with age rather than flooding the system with exogenous GH.

After age 30, women experience a progressive decline in growth hormone output that accelerates after menopause. This contributes to reduced muscle mass, increased fat accumulation (particularly visceral), poorer sleep quality, and slower tissue recovery. CJC-1295/Ipamorelin stacks address these issues by restoring more youthful GH pulsatility rather than supraphysiological levels.

For women 40+, the most commonly reported benefits are improved sleep quality (particularly deeper slow-wave sleep), modest improvements in body composition (more muscle, less fat), faster workout recovery, and improved skin quality over 3–6 months of consistent use. It is administered as a subcutaneous injection before bed to align with the natural nocturnal GH pulse. IGF-1 levels should be monitored during treatment to avoid excess growth hormone activity.

Thymosin Beta-4 (TB-500): Recovery and Anti-Inflammation

Thymosin Beta-4 is an actin-sequestering peptide with roles in cell migration, wound healing, and anti-inflammatory signaling. Like BPC-157, it has strong animal data for injury recovery and is increasingly used in clinical settings for musculoskeletal injuries, chronic inflammation, and neurological recovery. For women dealing with chronic inflammatory conditions, repetitive strain injuries, or post-surgical recovery, TB-500 is an emerging option — though like BPC-157, it awaits large-scale human RCTs.

What's NOT Worth It: Over-Hyped Peptides

The peptide market is flooded with compounds that have no meaningful human evidence and are sold primarily on social media hype. Women should be skeptical of: Epitalon (anti-aging claims based on cell culture and rodent data only), Selank and Semax (anxiolytic/nootropic peptides with almost no English-language human trial data), and any proprietary "peptide blends" sold without physician oversight. Without quality-tested pharmaceutical-grade compounds and physician monitoring, the risk-to-benefit ratio shifts unfavorably.

Evidence Summary by Peptide

Peptide	Primary Use Case for Women	Evidence Level	Administration
PT-141 (Bremelanotide)	Low sexual desire (HSDD)	High — FDA approved	Subcutaneous injection PRN
BPC-157	Gut healing, connective tissue recovery	Moderate — animal data strong; human limited	Oral or subcutaneous
GHK-Cu	Skin, hair, wound healing	Moderate — topical well-evidenced	Topical or subcutaneous
CJC-1295 / Ipamorelin	Body composition, sleep, recovery (40+)	Moderate — mechanistic + observational	Subcutaneous injection (nightly)
Thymosin Beta-4 (TB-500)	Injury recovery, anti-inflammation	Moderate — animal data strong; human emerging	Subcutaneous injection
Epitalon / Selank / Blends	Various anti-aging claims	Low — insufficient human data	Not recommended without strong evidence

Safety and Physician Oversight

No peptide should be used without physician oversight. Quality control is a serious issue in the peptide market — compounds sold without pharmaceutical-grade manufacturing standards may be mislabeled, contaminated, or incorrectly dosed. Physician-supervised peptide protocols use pharmacy-compounded or pharmaceutical-grade compounds with verified purity. Baseline labs (IGF-1, comprehensive metabolic panel) should be established before starting, and follow-up labs every 3–6 months during treatment.